Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Israel Steiner

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Annals of Neurology|September 10, 2011
On human disease and animal modelsIsrael Steiner
Neurology|May 20, 2009
Quantitative risk-benefit analysis of natalizumabIsrael Steiner
Nature Clinical Practice. Neurology|August 26, 2006
Can vaccinating older adults against varicella zoster virus prevent herpes zoster and postherpetic neuralgia?Israel Steiner
Current Opinion in Neurology|April 13, 2011
Herpes simplex virus encephalitis: new infection or reactivation?Israel Steiner
The Lancet. Neurology|May 25, 2010
PML: underdiagnosed in MS patients on natalizumabIsrael Steiner
Neurology|June 25, 2003
Treating post Lyme disease: trying to solve one equation with too many unknownsIsrael Steiner
Neurology|November 6, 2009
Past as prologue: delayed stroke as a parainfectious process of bacterial meningitis?Israel Steiner
Handbook of Clinical Neurology|August 13, 2013
Herpes virus infection of the peripheral nervous systemIsrael Steiner
Neurology|October 30, 2019
Reader response: Surgery and risk of Guillain-Barré syndrome: A French nationwide epidemiologic studyIsrael Steiner
Journal of the Neurological Sciences|November 20, 2021
Non-infectious mechanisms of neurological damage due to infectionFelix Benninger, Israel Steiner
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Annals of Neurology|September 10, 2011
On human disease and animal modelsIsrael Steiner
Neurology|May 20, 2009
Quantitative risk-benefit analysis of natalizumabIsrael Steiner
Nature Clinical Practice. Neurology|August 26, 2006
Can vaccinating older adults against varicella zoster virus prevent herpes zoster and postherpetic neuralgia?Israel Steiner
Current Opinion in Neurology|April 13, 2011
Herpes simplex virus encephalitis: new infection or reactivation?Israel Steiner
The Lancet. Neurology|May 25, 2010
PML: underdiagnosed in MS patients on natalizumabIsrael Steiner
Neurology|June 25, 2003
Treating post Lyme disease: trying to solve one equation with too many unknownsIsrael Steiner
Neurology|November 6, 2009
Past as prologue: delayed stroke as a parainfectious process of bacterial meningitis?Israel Steiner
Handbook of Clinical Neurology|August 13, 2013
Herpes virus infection of the peripheral nervous systemIsrael Steiner
Neurology|October 30, 2019
Reader response: Surgery and risk of Guillain-Barré syndrome: A French nationwide epidemiologic studyIsrael Steiner
Journal of the Neurological Sciences|November 20, 2021
Non-infectious mechanisms of neurological damage due to infectionFelix Benninger, Israel Steiner
Pageof 12